Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as Evidenced by

Curator: Aviva Lev-Ari, PhD, RN

 

 

UPDATED on 4/4/2022

Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech / Pharma Focus

Author: Aviva Lev-Ari, PhD, RN, Founder of 1.0 LPBI, 2012-2020 & 2.0 LPBI, 2021-2025 and Data Scientist, Research Assistant III: Tianzuo George Li

https://pharmaceuticalintelligence.com/2022/04/04/analytics-for-e-reputation-based-on-linkedin-1st-degree-connections-7500-of-lpbi-groups-founder-2012-2022-an-intangible-asset-connections-position-seniority-biotech-pharma-focus/

 

• e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point

• Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

WE ARE ON AMAZON.COM – 1/1/2018 – 13 e-Books in Medicine and Life Sciences

https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari

https://www.amazon.com/s/ref=dp_byline_sr_ebooks_9?ie=UTF8&text=Aviva+Lev-Ari&search-alias=digital-text&field-author=Aviva+Lev-Ari&sort=relevancerank

 

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

http://www.amazon.com/dp/B071VQ6YYK

https://www.amazon.com/dp/B075CXHY1B

https://www.amazon.com/dp/B076HGB6MZ

https://www.amazon.com/dp/B078313281

https://www.amazon.com/dp/B078QVDV2W

 

FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 1/29/2018

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2017/04/28/five-years-of-e-scientific-publishing-pharmaceuticalintellicence-com-top-articles-by-author-and-by-e-views-1000-4272012-to-4272017/

 

Top Authors, by +5 years of e-Views, 1/29/2018, on pharmaceuticalintelligence.com

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2017/04/25/top-authors-by-5-years-of-e-views-4252017-on-pharmaceuticalintelligence-com/

 

Digital Presence measured by eViews:  Clicks on articles by Author Name

Top Authors for all days ending 2018-05-28 (Summarized)

1. Our 15 e-Books in Genomics and Medicine were on Display at the Publication Desk of CHI @CHI’s 14th Annual Discovery on Target took place September 19 – 22, 2016 in Boston, Westin Boston Waterfront

https://pharmaceuticalintelligence.com/2016/09/17/our-15-e-books-in-genomics-and-medicine-on-display-at-the-publication-desk-of/

2. New e-Book TITLES forthcoming on Amazon.com in 2018 from LPBI Group’s BioMed e-Series

• Volume Five:Pharmacological Agents in Treatment of Cardiovascular Diseases

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-five-pharmaco-therapies-for-cvd/

• Volume Six: Interventional Cardiology and Cardiac Surgery for Disease Diagnosis and Guidance of Treatment

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-six-interventional-cardiology-and-cardiac-surgery/

• Genomics Volume 2: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-two-genomics-methodologies-ngs-bioinformatics-simulations-and-the-genome-ontology/

3. June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com

https://pharmaceuticalintelligence.com/2016/06/19/june-19-2016-we-celebrate-reaching-over-one-million-e-readers-pharmaceuticalintelligence-com/

4. Founder

https://pharmaceuticalintelligence.com/founder/

5. Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence: Contributions of Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2014/10/16/editorial-publication-of-articles-in-e-books-by-leaders-in-pharmaceutical-business-intelligence-contributions-of-aviva-lev-ari-phd-rn/

6. Corporate Clients for our Services: Funding Medical Devices Development & Biologics

https://pharmaceuticalintelligence.com/joint-ventures/corporate-clients-for-our-services/

7. REAL TIME Press Coverage for Biotech and Medicine, Scientific and Business Investment International Conferences

List of Conferences Covered in Real Time by

Aviva Lev-Ari, PhD, RN on Press Pass, 2013 – Present

Year	# Conferences covered in Real Time	Conference Organizers
2020
2019
2018	10	MassBio, AI,ML&CL, MassBio-Devices&Drugs, WMIF-AI-Partners, US-India BioPharma, BioIT, BIO 2018!, Koch@MIT, , CHI-DiscoveryonTarget, PMC-HMS
2017	12	MassBio, WMIF-CVD-Partners, US-India BioPharma, BioIT, Koch@MIT, CHI-IO CHI OncoVirus IO, WarrenLecture-HMS, HubWeek, Koch@MIT, EmTech@MIT, PMC-HMS
2016	8	MassBio, WMIF-Cancer-Partners, US-IndiaBioPharma, CHI-IO, CHI-OncoVirus IO, CHI DiscoveryonTarget, EmTech @MIT, PMC-HMS
2015	5	PMWC-SiliconVallley, MassBio, BioIT, EmTech@MIT, PMC-HMS,
2014	7	SacksAssoc-NY, MassBio, BioIT Koch@MIT, SacksAssoc-Basel, Brandeis, PMC-HMS,
2013	1	BioIT

https://pharmaceuticalintelligence.com/press-coverage/

8. Social Media Influence and Channels for Content e-Marketing 

• Our Journal has 1,436,050 eReaders, 2,339 subscribers and 7,291 Scientific Comments on 28/5/2018, for All Time, 28/4/2012 – 28/5/2018

http://pharmaceuticalintelligence.com

• Aviva has +6,592 BIOTECH Followers on LinkedIn

http://www.linkedin.com/in/avivalevari

• Aviva is a Member of +60 LinkedIn Groups in Biotech-related fields

https://www.linkedin.com/groups/my-groups

• LPBI Group’s FaceBook Page

http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

• LPBI Group’s Twitter Account with hundreds of followers

http://twitter.com/pharma_BI

Tweets by AVIVA1950

• Aviva is a LinkedIn (LI) Group Launcher and Manager of Three LI Groups
  

  Cardiovascular Biotech & Pharma UK & US Networking Group

  918 members (1/2018)

  Leaders in Pharmaceutical Business Intelligence

  344 members (1/2018)

  Innovation in Israel

  191 members (1/2018)

• LPBI Group’s Company’s Page on LinkedIn

https://www.linkedin.com/company/9325543?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A9325543%2Cidx%3A1-1-1%2CtarId%3A1439226813927%2Ctas%3ALeaders%20in%20Pharmaceutica

Additional LINKS on Professional Activities as Parameters of the Key Opinion Leader

• Scientific and Medical Affairs Chronological CV

• HealthCare Delivery – Long Term Post Acute Care Nursing Management CV

• Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence

• List of Publications, 2006 – Present

• Cardiovascular Diseases and Pharmacological Therapy: Curations, 2006 – 4/2018

• MedTech & Medical Devices for Cardiovascular Repair – Curations

• Stem Cells and Cardiac Repair: Content Curation & Scientific Reporting

• Regulatory Affairs: Publications on FDA-related Issues – Aviva Lev-Ari, PhD, RN

• Cancer Research: Curations and Reporting